Keyes Stange & Wooten Wealth Management LLC Raises Stock Position in Daxor Co. (NASDAQ:DXR)

Keyes Stange & Wooten Wealth Management LLC grew its stake in Daxor Co. (NASDAQ:DXR) by 34.8% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 14,612 shares of the company’s stock after acquiring an additional 3,771 shares during the period. Keyes Stange & Wooten Wealth Management LLC owned about 0.30% of Daxor worth $126,000 as of its most recent filing with the SEC.

Analyst Upgrades and Downgrades

Separately, Ascendiant Capital Markets upped their target price on shares of Daxor from $24.50 to $24.75 and gave the company a “buy” rating in a report on Monday, September 9th.

Daxor Trading Up 4.0 %

Shares of DXR opened at $9.28 on Friday. The company has a 50-day simple moving average of $9.03 and a 200-day simple moving average of $9.02. Daxor Co. has a 52-week low of $7.11 and a 52-week high of $10.04.

Daxor Profile

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.